Delaware
(State
or Other Jurisdiction
of
Incorporation)
|
000-30929
(Commission
File Number)
|
13-4087132
(IRS
Employer Identification No.)
|
£ |
Written
communications pursuant to Rule 425 under the Securities
Act.
|
£ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange
Act.
|
£ |
Pre-commencement
communications pursuant to Rule 14d-2b under the Exchange
Act.
|
£ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act.
|
Item
8.01.
|
Other
Events.
|
Item 9.01. |
Financial
Statements and Exhibits.
|
Exhibit
Number
|
Description |
99.1 |
Press
Release dated March 7, 2008.
|
Keryx
Biopharmaceuticals, Inc.
(Registrant)
|
||
|
|
|
Date: March 7, 2008 | By: | /s/ Beth F. Levine |
Beth F. Levine |
||
Senior Vice President, Chief Compliance Officer, General Counsel and Secretary |
Exhibit
Number
|
Description |
99.1 |
Press
Release dated March 7, 2008.
|